Recent studies implicated particular HDAC isoforms, HDAC2, HDAC3, HDAC6, HDAC9, and HDAC10, in chronic intestinal inflammation and, thus, selective HDACis serve as attractive therapeutic options for IBD [22,25,28,34,35]. This evidence concerns the gene HDAC10 and inflammatory bowel disease.